Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Soluble VE-cadherin and VE-cadherin Antibody in Sclerodermic Sclerosis

NCT02212249 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.

NCT NCT02212249
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02212249 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Soluble VE-cadherin and VE-cadherin Antibody in Sclerodermic Sclerosis
Lead sponsor
University Hospital, Grenoble
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2014
Completion date
March 31, 2016
Enrollment
85 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary raynaud disease, systemic sclerosis